A study to see how homoeopathic treatment helps to reduce heavy menstrual bleeding in women with fibroids

Effect of individualised homoeopathic medicines in abnormal uterine bleeding of leiomyoma in nongestational women - A prospective single arm clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108118

Enrollment

Registered

2026-04-10

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N938- Other specified abnormal uterine and vaginal bleeding

Interventions

Intervention1: Individualised homoeopathic medicines: individualised homoeopathic medicines in various potencies according to totality of symptoms and principles of homoeopathy for 3 months Control In

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cases fulfilling the working case definition criteria 2. Females Age group between 28-45 years of age

Exclusion criteria

Exclusion criteria: 1.Haemoglobin less than 8gm%. 2.Haemodynamically unstable patients. 3.Pregnancy and lactation. 4.Women using IUCD/OCP. 5.Postmenopausal women. 6.Uterine fibroid size less than 2cm and more than 8cm. 7.Known cases of malignancy. 8.Patients with severe systemic disease like hypertension, diabetes mellitus. 9.Patients having thyroid dysfunction with TSH less than 0.5 mIU/ml and more than 5mIU/ml. 10.Other uterine diseases presenting with abnormal uterine bleeding. 11.Complications of fibroid like torsion and acute urinary retention.

Design outcomes

Primary

Measure	Time frame
1.Severity of abnormal uterine bleeding of leiomyoma assessed by pictorial blood loss assessment score . 2.Assessing the quality of life using menstrual bleedingquestionnaire . Timepoint: 1.changes in pictorial blood loss assessment score from baseline and third month of treatment with individualised homoeopathic medicines. 2.changes in the quality of life using menstrual bleedingquestionnaire from baseline and third month of treatment with individualised homoeopathic medicines.	—

Measure

Time frame

1.Severity of abnormal uterine bleeding of leiomyoma assessed by pictorial blood loss assessment score . 2.Assessing the quality of life using menstrual bleedingquestionnaire . Timepoint: 1.changes in pictorial blood loss assessment score from baseline and third month of treatment with individualised homoeopathic medicines. 2.changes in the quality of life using menstrual bleedingquestionnaire from baseline and third month of treatment with individualised homoeopathic medicines.

—

Secondary

Measure	Time frame
1.Changes in duration of bleeding per cycle . 2.Changes in Haemoglobin level 3.Changes in size of uterine fibroid evaluated by USG abdomen &pelvis.Timepoint: 1.Changes in duration of bleeding per cycle at baseline and third month of treatment with individualized homoeopathic medicine. 2.Changes in Haemoglobin level measured at baseline and third month treatment with individualized homoeopathic medicines. 3.Changes in size of uterine fibroid evaluated by USG abdomen &pelvis before after treatment with individualized homoeopathic medicines	—

Measure

Time frame

1.Changes in duration of bleeding per cycle . 2.Changes in Haemoglobin level 3.Changes in size of uterine fibroid evaluated by USG abdomen &pelvis.Timepoint: 1.Changes in duration of bleeding per cycle at baseline and third month of treatment with individualized homoeopathic medicine. 2.Changes in Haemoglobin level measured at baseline and third month treatment with individualized homoeopathic medicines. 3.Changes in size of uterine fibroid evaluated by USG abdomen &pelvis before after treatment with individualized homoeopathic medicines

—

Countries

India

Contacts

Public ContactDr Thara K

Government Homoeopathic Medical College Kozhikode

drthararaj@gmail.com9745245755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026